Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery
OPEN ACCESS
Loading...
Author / Producer
Date
2005-04
Publication Type
Review Article
ETH Bibliography
yes
OPEN ACCESS
Data
Rights / License
Abstract
Pancreatic cancer is a uniformly lethal disease that is difficult to diagnose at early stage and even more difficult to cure. In recent years, there has been a substantial interest in applying proteomics technologies to identify protein biomarkers for early detection of cancer. Quantitative proteomic profiling of body fluids, tissues, or other biological samples to identify differentially expressed proteins represents a very promising approach for improving the outcome of this disease. Proteins associated with pancreatic cancer identified through proteomic profiling technologies could be useful as biomarkers for the early diagnosis, therapeutic targets, and disease response markers. In this article, we discuss recent progress and challenges for applying quantitative proteomics technologies for biomarker discovery in pancreatic cancer.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
4 (4)
Pages / Article No.
523 - 533
Publisher
American Society for Biochemistry and Molecular Biology
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Organisational unit
03663 - Aebersold, Rudolf (emeritus) / Aebersold, Rudolf (emeritus)